Anemia Evaluation and Management in a 12-Month-Old Infant
Screen all 12-month-old infants for anemia with a hemoglobin or hematocrit measurement, and if anemia is detected (hemoglobin <11 g/dL), obtain a complete blood count with mean corpuscular volume (MCV) to guide further evaluation and treatment 1, 2.
Screening Approach
The American Academy of Pediatrics recommends universal screening before 1 year of age, ideally at the 12-month well-child visit 1, 2. This timing allows sufficient time for nutritional anemia to develop after weaning from iron-fortified formula and captures the peak risk period for iron deficiency anemia, which is the most common cause of anemia in this age group 2, 3.
Initial screening consists of:
- Hemoglobin or hematocrit measurement
- If anemia is present (Hb <11 g/dL or Hct <33%), obtain a complete blood count with MCV and red cell distribution width (RDW) 1, 4
The RDW is particularly useful at this age—an abnormal RDW predicts identifiable causes of anemia (iron deficiency, thalassemia, hemoglobinopathies), while a normal RDW makes these conditions unlikely 4.
Evaluation Algorithm Based on MCV
Microcytic Anemia (Low MCV)
This is the most common pattern in 12-month-olds 1, 2.
Most likely causes:
- Iron deficiency anemia (most common)
- Thalassemia trait
- Lead toxicity (if environmental exposure risk)
Workup approach:
- Start empiric iron therapy with ferrous sulfate 2-6 mg/kg/day of elemental iron 1
- Recheck hemoglobin after 1 month of treatment
- If hemoglobin rises ≥1 g/dL, this confirms iron deficiency anemia—continue iron for 2-3 months to replete stores 4
- If no response to iron therapy, obtain hemoglobin electrophoresis to evaluate for thalassemia and consider lead level if risk factors present 4
Normocytic Anemia (Normal MCV)
Next step: Obtain reticulocyte count 1, 2
- High reticulocyte count suggests hemolysis or acute blood loss—evaluate for hemolytic anemias (membranopathies, enzymopathies, immune-mediated destruction)
- Low reticulocyte count indicates bone marrow suppression—requires urgent pediatric hematology referral 1
Macrocytic Anemia (High MCV)
This is uncommon in 12-month-olds 1, 2.
Evaluate for:
- Vitamin B12 deficiency (especially in exclusively breastfed infants of vegan mothers)
- Folate deficiency
- Hypothyroidism
- Bone marrow disorders
Treatment Specifics
For confirmed iron deficiency anemia:
- Ferrous sulfate 2-6 mg/kg/day of elemental iron is the most effective oral supplementation 1
- Give between meals with vitamin C source to enhance absorption
- Continue for 2-3 months after hemoglobin normalizes to replete iron stores
- Expect hemoglobin rise of ≥1 g/dL after 1 month of therapy
Common pitfall: Giving iron with milk or meals reduces absorption—advise parents to give iron separately from dairy products.
When to Refer to Pediatric Hematology
Immediate referral needed for:
- Any bone marrow suppression (low reticulocyte count with normocytic anemia) 1
- Failure to respond to appropriate iron therapy after 1 month
- Severe anemia (hemoglobin <7 g/dL) at presentation
- Suspected hemolytic process
Prevention Considerations
While delayed cord clamping at birth can prevent early iron deficiency, this is a delivery room intervention and not applicable to evaluation at 12 months 1, 2. The focus at this age is on identifying and treating existing anemia and ensuring adequate dietary iron intake going forward.
Key risk factors to assess in history:
- Exclusive breastfeeding without iron supplementation
- Consumption of >24 oz/day of cow's milk
- Low dietary iron intake
- Prematurity or low birth weight
- Recent rapid growth
The neurodevelopmental consequences of iron deficiency (with or without anemia) can be long-lasting, making identification and treatment at 12 months critical 3.